BlackRock, Inc. (BLK) 13D/13G Filings for Keros Therapeutics, Inc. (KROS)

BlackRock, Inc. 13D and 13G filings for Keros Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-01-26
5:26 pm
Purchase		 2023-12-31 13G Keros Therapeutics, Inc.
KROS		 BlackRock Inc.
BLK		 2,036,788
6.800%		 398,462increase
(+24.32%)		 Filing
2023-02-07
11:06 am
Purchase		 2022-12-31 13G Keros Therapeutics, Inc.
KROS		 BlackRock Inc.
BLK		 1,638,326
5.900%		 351,800increase
(+27.34%)		 Filing
2022-02-03
4:29 pm
Purchase		 2021-12-31 13G Keros Therapeutics, Inc.
KROS		 BlackRock Inc.
BLK		 1,286,526
5.500%		 87,325increase
(+7.28%)		 Filing
2021-02-02
3:13 pm
Purchase		 2020-12-31 13G Keros Therapeutics, Inc.
KROS		 BlackRock Inc.
BLK		 1,199,201
5.200%		 1,199,201increase
(New Position)		 Filing